Overview
Status
Active
Registry date
2019-02-13
Share capital
5 000,00 PLN
Registered address
ul. Przejazd 2A/403, 15-430 Białystok, Poland
Electronic delivery address
AE:PL-41303-52382-GIVFW-31
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 472 days for 2020).
- 202517/08/2026
- 202406/08/2025
- 202321/06/2024
- 202221/06/2024
- 202130/01/2023
- 202030/01/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 989.75kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 423.90kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 521.69kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 483.80kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Małgorzata Siergiejenko – Management Board Member
Tihon Sergeenko – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tihon Sergeenkoage 43 | 45 | $607.78 | 45% |
Małgorzata Siergiejenkoage 37 | 55 | $742.84 | 55% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-02-22.
43 2490 0005 0000 4600 5827 7543
55 2490 1057 0000 9902 1044 3440
64 2490 1057 0000 9900 1044 3440
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | STAROSTA POWIATU BIAŁYSTOCKIEGO |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Cirrosp. z o.o. | $20,863,166.14 | cirro.pl | ||
| Premmier Redsp. z o.o. | $2,723,178.99 | premmier.com | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Polcoresp. z o.o. | $1,015,341.48 | polcore.pl | ||
| Surgical Solutionssp. z o.o. | $947,852.75 | surgical-solutions.pl | ||
| Meditechsp. z o.o. | $934,565.46 | meditech.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| Temedasp. z o.o. | – | temeda.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-01-24 | Address change (Ul. Warszawska 6/32, 15-063, Białystok → Ul. Przejazd 2a/403, 15-430, Białystok) | |
| 2019-02-13 | Entered in the register |
FAQ
The main business activity of Techstar focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 13, 2019.
The headquarters is located at: ul. Przejazd 2A, 15-430 Białystok.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 989,753, representing an increase of 51.3% compared to 2024.
Yes, the company recorded a net profit of USD 423,904 in 2025, meaning the company increased its profit by 83.2%.
The largest operating cost category falls under other operating costs. This category amounted to USD 505,082 in 2025, representing 97% of all operating expenses.
Last updated: 2026-08-17